Although oligodendrogliomas cannot be considered benign tumors, many a
re slow-growing indolent tumors for which prolonged life expectancy is
the rule. Others behave in a more aggressive, malignant fashion, as t
heir histologic characteristics would predict. The treatment for oligo
dendrogliomas is evolving, with conservative management still reserved
for nonanaplastic tumors, and increasingly aggressive systemic therap
ies are being developed for more aggressive or recurrent tumors.